entity

METHYLATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about METHYLATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
21Hypotheses
0Analyses
3Outgoing
2Incoming
12Experiments
0Debates

No AI portrait yet

Outgoing (3)

TargetRelationTypeStr
HPA Axisregulatespathway0.90
HPA AXIS RELATED GENESmodulatesgene0.90
Epigenomic Reconfigurationcomponent_ofprocess0.85

Incoming (2)

SourceRelationTypeStr
PROTEIN ARGININE METHYLTRANSFERASEScatalyzesenzyme0.90
C9orf72 Repeat Expansionassociated_withbiomarker0.90

Targeting Hypotheses (21)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
p38α Inhibitor and PRMT1 Activator Combination to Restore Ph 0.879 neurodegeneration What is the therapeutic window between i
TET2-Mediated Demethylation Rejuvenation Therapy 0.706 neurodegeneration Epigenetic clocks and biological aging i
Temporal TET2-Mediated Hydroxymethylation Cycling 0.657 neurodegeneration Epigenetic reprogramming in aging neuron
Arginine Methylation Enhancement Therapy 0.653 neurodegeneration TDP-43 phase separation therapeutics for
CX3CR1 Promoter Methylation Disrupts Neuron-Microglia Cross- 0.649 developmental neurobiology Do perinatal immune challenges create pe
Neuronal TET1 Upregulation Reactivates Immediate-Early Genes 0.640 neurodegeneration epigenetic reprogramming aging neurons
TREM2 Promoter Silencing via DNA Hypermethylation 0.576 developmental neurobiology Do perinatal immune challenges create pe
Targeted DNA Demethylation at the Klotho Locus via dCas9-TET 0.510 neurodegeneration epigenetic reprogramming aging neurons
DNA Methylation Clock Drift at Glial Promoters 0.480 neurodegeneration Comparative epigenetic signatures: DNA m
DNMT3A-Mediated de novo Methylation Corrects 'Epigenetic Sca 0.460 neurodegeneration Investigate mechanisms of epigenetic rep
DNA Hypomethylation at P2RY12 Promoter Correlates with Disea 0.440 neurodegeneration What determines P2RY12 receptor expressi
Small-Molecule Modulation of G3BP1 Condensate Dynamics via P 0.400 neurodegeneration How do disease-associated mutations in G
DNMT1 Downregulation to Correct Genome-Wide Hypomethylation 0.380 neurodegeneration Comparative epigenetic signatures across
TET Enzyme Enhancement to Prevent Aberrant DNA Methylation 0.350 neurodegeneration Comparative epigenetic signatures across
Autophagy-Epigenetic Feedback Loop Creates a Compounding Bio 0.347 - Epigenetic clocks as biomarkers for Alzh
protective chromatin remodeling defines the therapeutic wind 0.345 neurodegeneration Are DNA methylation changes in neurodege
age-linked CpG drift is the actionable driver in: Are DNA me 0.344 neurodegeneration Are DNA methylation changes in neurodege
age-linked CpG drift is the actionable driver in: Are age-re 0.344 neurodegeneration Are age-related DNA methylation changes
ATAC-seq accessibility separates causal from compensatory st 0.342 neurodegeneration Are DNA methylation changes in neurodege
ATAC-seq accessibility separates causal from compensatory st 0.327 neurodegeneration Are age-related DNA methylation changes
protective chromatin remodeling defines the therapeutic wind 0.326 neurodegeneration Are age-related DNA methylation changes

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (12)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
MAPK pathway inhibition by QTJD through butyrate mechanism exploratory Mycoplasma pneumoniae pneumoni 0.900 0.00 Mouse macrophages proposed N/A
Tet2 modulation in Aβ42-injured mouse hippocampal neurons exploratory Alzheimer's disease 0.900 0.00 primary mouse hippocampal neur proposed N/A
AAV-mediated Tet2 modulation in 2×Tg-AD mice behavioral study validation Alzheimer's disease 0.900 0.00 young APPswe/PSEN1 double-tran proposed N/A
Network pharmacology screening of ginger targets against gastric cance exploratory gastric cancer 0.900 0.00 computational analysis using h proposed N/A
Tet2 expression analysis in aged 2×Tg-AD mouse brains exploratory Alzheimer's disease 0.850 0.00 APPswe/PSEN1 double-transgenic proposed N/A
Molecular docking validation of ginger-PRMT1 interactions exploratory gastric cancer 0.800 0.00 computational molecular dockin proposed N/A
Proposed experiment from debate on Epigenetic clocks and biological ag falsification Neurodegeneration 0.400 0.50 mouse completed $450,000
DNA Damage Repair Deficiency Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human completed $7,500,000
Epigenetic Clocks in Neurodegeneration — Causal Drivers or Passive Mar validation Neurodegeneration 0.400 0.50 human completed $3,000,000
Epigenetic Dysregulation Validation in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $7,500,000
Epigenetic Regulation Dysfunction in Alzheimer's and Parkinson's Disea clinical Alzheimer's Disease 0.400 0.50 human proposed $7,500,000
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Never Develo validation Parkinson's Disease 0.400 0.50 human completed $2,730,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Predicting the molecular mechanism of ginger targeting PRMT1/BTG2 axis to inhibi [PMID:40446574] Chen G, Gou B, Du Y, Zhou Z, Bai Y, Yang Phytomedicine 2025 1
PRMT1 promotes pancreatic cancer development and resistance to chemotherapy. [PMID:38460517] Ku B, Eisenbarth D, Baek S, Jeong TK, Ka Cell Rep Med 2024 1
PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemor [PMID:38383964] Yamamoto T, Hayashida T, Masugi Y, Oshik Cancer Res 2024 1
Promising role of protein arginine methyltransferases in overcoming anti-cancer [PMID:37980859] Zhu Y, Xia T, Chen DQ, Xiong X, Shi L, Z Drug Resist Updat 2024 1
Protein arginine methylation: from enigmatic functions to therapeutic targeting. [PMID:33742187] Wu Q, Schapira M, Arrowsmith CH, Barsyte Nat Rev Drug Discov 2021 1
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. [PMID:33398264] Turner JS, Kim W, Kalaidina E, Goss CW, Res Sq 2020 1
Reply to Rosen: Temperature-growth relationship is robust. [PMID:31375623] Diffenbaugh NS, Burke M Proc Natl Acad Sci U S A 2019 1
Cryo-electron microscopy structures of human oligosaccharyltransferase complexes [PMID:31831667] Ramírez AS, Kowal J, Locher KP Science 2019 1
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] Krasemann S, Madore C, Cialic R, Baufeld Immunity 2017 1
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with [PMID:28068668] Britschgi A, Duss S, Kim S, Couto JP, Br Nature 2017 1
CD161 defines a transcriptional and functional phenotype across distinct human T [PMID:25437561] Fergusson JR, Smith KE, Fleming VM, Rajo Cell Rep 2014 1
Genome-wide methylation profiles reveal quantitative views of human aging rates. [PMID:23177740] Hannum G, Guinney J, Zhao L, Zhang L, Hu Mol Cell 2013 1
Tet methylcytosine dioxygenase 2(TET2)-dependent epigenetic regulation in the pa [PMID:41811389] Liu K, Hong Y, Gao Q, Huang J, Liu L, Li Cellular and molecular life sc 2026 0
Repression of PRMT activities sensitize human homologous recombination-proficien [PMID:41632514] ["Zhang Y", "Xu M", "Yuan J", "Hu Z", "J eLife 2026 0
IRG1-itaconate axis in immunometabolism: mechanistic roles and therapeutic poten [PMID:41743716] Liu Y, Zhang P, Kong W, Li J, Yang H, Ba Frontiers in immunology 2026 0
Ginsenoside RG3 and cantharidin synergistically suppress the progression of hepa [PMID:41501793] ["Wang Y", "Yuan H", "Yu Y", "Gou X", "W Journal of translational medic 2026 0
DNA Methylation in the Ovary and Uterus of Mammalian Animal Models: Implications [PMID:41751612] Serej O, Kowalik MK, Rekawiecki R Genes 2026 0
Promoter demethylation and protein O-GlcNAcylation-mediated enhancement of fatty [PMID:41360204] Lin ZH, Chou PI, Chang JW, Lin ZC, Sun Y J Nutr Biochem 2026 0
Protein arginine methyltransferases in cancer: mechanisms, functions, and therap [PMID:41928257] Jeong Y, Cho Y, Kim YK J Biomed Sci 2026 0
Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoc [PMID:41739588] Yonekawa J, Yura Y, Luo J, Kato K, Ikeda The Journal of clinical invest 2026 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning METHYLATION in their description or question text

Neuronal TET1 Upregulation Reactivates Immediate-Early Genes and Restores Dendri

Score: 0.640 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The hypothesis centers on the ten-eleven translocation 1 (TET1) enzyme's critical

TREM2 Promoter Silencing via DNA Hypermethylation

Score: 0.576 · developmental neurobiology · 2026-04-21

**Molecular Mechanism and Rationale** The proposed hypothesis centers on the epigenetic silencing of TREM2 (Triggering

Targeted DNA Demethylation at the Klotho Locus via dCas9-TET1 Rescues Neuroprote

Score: 0.510 · neurodegeneration · 2026-04-22

## Mechanistic Overview Targeted DNA Demethylation at the Klotho Locus via dCas9-TET1 Rescues Neuroprotective Klotho Exp

DNA Methylation Clock Drift at Glial Promoters

Score: 0.480 · neurodegeneration · 2026-04-25

DNA Methylation Clock Drift at Glial Promoters

DNMT3A-Mediated de novo Methylation Corrects 'Epigenetic Scars' at Polycomb Targ

Score: 0.460 · neurodegeneration · 2026-04-21

## Mechanistic Overview DNMT3A-Mediated de novo Methylation Corrects 'Epigenetic Scars' at Polycomb Targets starts from

DNA Hypomethylation at P2RY12 Promoter Correlates with Disease Progression

Score: 0.440 · neurodegeneration · 2026-04-21

## Mechanistic Overview DNA Hypomethylation at P2RY12 Promoter Correlates with Disease Progression starts from the claim

Small-Molecule Modulation of G3BP1 Condensate Dynamics via PRMT1 Methylation as

Score: 0.400 · neurodegeneration · 2026-04-22

## Mechanistic Overview Small-Molecule Modulation of G3BP1 Condensate Dynamics via PRMT1 Methylation as a Therapeutic St

DNMT1 Downregulation to Correct Genome-Wide Hypomethylation

Score: 0.380 · neurodegeneration · 2026-04-25

DNMT1 Downregulation to Correct Genome-Wide Hypomethylation

TET Enzyme Enhancement to Prevent Aberrant DNA Methylation

Score: 0.350 · neurodegeneration · 2026-04-25

TET Enzyme Enhancement to Prevent Aberrant DNA Methylation

Autophagy-Epigenetic Feedback Loop Creates a Compounding Biomarker Signal — Auto

Score: 0.347 · unknown disease · 2026-04-25

Concise Statement: Progressive failure of autophagy flux in AD neurons produces a cascading epigenetic feedback loop —

protective chromatin remodeling defines the therapeutic window for: Are DNA meth

Score: 0.345 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell meth

age-linked CpG drift is the actionable driver in: Are DNA methylation changes in

Score: 0.344 · neurodegeneration · 2026-04-26

The gap can be tested by treating age-linked CpG drift as an upstream driver rather than a passive correlate. If true, p

age-linked CpG drift is the actionable driver in: Are age-related DNA methylatio

Score: 0.344 · neurodegeneration · 2026-04-26

The gap can be tested by treating age-linked CpG drift as an upstream driver rather than a passive correlate. If true, p

ATAC-seq accessibility separates causal from compensatory states in: Are DNA met

Score: 0.342 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada

ATAC-seq accessibility separates causal from compensatory states in: Are age-rel

Score: 0.327 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada